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a b s t r a c t 
Decades of research in orthopaedics has culminated in the quest for formidable yet resorbable bioma- 
terials using bioactive materials. Brushite cements most salient features embrace high biocompatibility, 
bioresorbability, osteoconductivity, self-setting characteristics, handling, and injectability properties. Such 
type of materials is also effectively applied as drug delivery systems. However, brushite cements pos- 
sess limited mechanical strength and fast setting times. By means of incorporating bioactive ions, which 
are incredibly promising in directing cell fate when incorporated within biomaterials, it can yield bio- 
materials with superior mechanical properties. Therefore, it is a key to develop fine-tuned regenerative 
medicine therapeutics. A comprehensive overview of the current accomplishments of ion-doped brushite 
cements for bone tissue repair and regeneration is provided herein. The role of ionic substitution on 
the cements physicochemical properties, such as structural, setting time, hydration products, injectability, 
mechanical behaviour and ion release is discussed. Cell-material interactions, osteogenesis, angiogenesis, 
and antibacterial activity of the ion-doped cements, as well as its potential use as drug delivery carriers 
are also presented. 
© 2021 Acta Materialia Inc. Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license 


































The population ageing and the consequent increase in the in- 
idence of bone diseases (e.g. osteoporosis, osteoarthritis, and os- 
eomyelitis) and trauma related injuries, resulting from primary tu- 
our resection and orthopaedic surgeries (e.g. total joint arthro- 
lasty and implant fixation), have caused a growing demand for 
one filling and repair materials [1] . To overcome this multiplic- 
ty of pathologies and injuries, the treatments used by orthopaedic 
urgeons are mainly internal fixation and bone grafts implantation 
 2 , 3 ]. Autogenous grafts (transplant of tissue from one to another
art of the body in the same patient) are among the most success- 
ul, but they face a number of limitations regarding the poor avail- 
bility of collected tissue, chronic donor site pain, morbidity, and 
omplications at the site of harvest. Allogeneic grafts (transplant of 
issue from one to another patient with a different genotype) and ∗ Correspondence authors. 
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lso have several drawbacks, among which the risk of immune- 
ediated rejection and infectious disease transmission. 
Given the risks of infection and contamination from the nat- 
ral origin materials, the discovery of synthetic materials as cal- 
ium phosphate-based cements (CPCs) has opened a new era in 
he medical field of bone grafting [4] . This type of biomaterials is 
nown for its outstanding biocompatibility, resorbability, osteocon- 
uctivity, moldability and injectability, and complete filling of any 
efect geometry [1] . Currently, several CPCs formulations are avail- 
ble for clinical practice as shown in Table 1 [5] . 
According to their final hydration product, CPCs can be clas- 
ified as apatite and brushite cements [6] . Apatite formation oc- 
urs at pH > 4.2, while brushite precipitates at more acidic con- 
itions at pH < 4.2, at 37 °C [ 7 , 8 ]. Brushite cements were ob-
ained by Mirtchi et al. [9] in 1989, by mixing β-tricalcium phos- 
hate (Ca 3 (PO 4 ) 2 , β-TCP) and monocalcium phosphate monohy- 
rate (Ca(H 2 PO 4 ) 2 ·H 2 O, MCPM). These cements have faster setting 
imes and higher resorbability, under physiological conditions, than 
patite cements. Brushite is degraded by simple chemical dissolu- 
ion, while degradation of apatite requires osteoclast activity [10] . ticle under the CC BY-NC-ND license 
ped Brushite Cements for Bone Regeneration, Acta Biomaterialia, 
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Table 1 
Commercially available CPCs for orthopaedics applications [5] . 
Company Product Composition End product 
Produits Dentaires SA (CH) VitalOs β-TCP, Na 2 H 2 P 2 O 7 
MCPM, CaSO 4 ·2H 2 O 
Brushite 
Synthes (US) ChronOS Inject R © 73 wt% β-TCP, 21 wt% MCPM, 5 wt% MgHPO 4 ·3H 2 O, < 1 wt% MgSO 4 , < 1 wt% 
Na 2 H 2 P 2 O 7 
Brushite 
ETEX (US) α-BSM R © 50 wt% ACP, 50 wt% DCPD Apatite 
beta-BSM R © n.d. 
CarriGen CaPs, sodium carboxymethylcellulose, and sodium carbonate 
OssiPro n.d. 
Mitsubishi Materials (JP) Biopex α-TCP, TTCP, DCPD Apatite 
Stryker (US) BoneSource TM 73 wt% TTCP, 27 wt% DCPD Apatite 
HydroSet TM DCPD, TTCP, Trisodium citrate 
BerKeley Advanced Biomaterials (US) Cem-Ostetic TM n.d. Apatite 
Tri-Ostetic TM n.d. 
Rebone Biomaterials (CHN) Rebone TTCP, DCPA Apatite 
Skeletal Kinetics (US) Callos TM α-TCP, CaCO 3 , MCPM Apatite 
Callos Inject TM α-TCP 
OsteoVation EX Inject n.d. 
Biomet (US) Calcibon R © 61 wt% α-TCP, 26 wt% DCPA, 10 wt% CaCO 3 , 3 wt% CDHA Apatite 
Biocement D α-TCP, DCP, CaCO 3 , PHA Apatite 
Synthes (US) Norian SRS R ©
Norian CRS R ©
85 wt% α-TCP, 12 wt% CaCO 3 , 3 wt% MCPM Apatite 
Lorenz Surgical (GER) Mimix TM α-TCP, TTCP, HA, citric acid Apatite 
Calcitec (US) Osteofix CaPs, CaO Apatite 
Teknimed (FR) Cementek TTCP, α-TCP, sodium glycerophosphate Apatite 
Cementek LV TTCP, α-TCP, sodium glycerophosphate, dimethylsyloxane 
ACP: Amorphous calcium phosphate; CaPs: calcium phosphates; DCPA: dicalcium phosphate anhydrate; DCPD: dicalcium phosphate dihydrate; MCPM: monocalcium phos- 




































































d  herefore, brushite cements are of special interest for applications 
here replacement of the cement by newly forming bone is de- 
ired. In contrast, apatite cements have better mechanical strength 
han brushite cements [5] . 
It is well known that the presence of bioactive ions (e.g., Mg 2 + , 
r 2 + , Zn 2 + , Mn 2 + , Cu 2 + , Li + , Co 2 + , Cr 3 + , and Ag + ), into the struc-
ure of calcium phosphates (CaPs) plays an essential part during 
he biological action course of the final CPCs, as well as their fi- 
al mechanical properties [ 11 , 12 ]. Mg 2 + was shown to prevent risk
actors for osteoporosis and can induce angiogenesis [ 13 , 14 ]. Sr 2 + is
eported to inhibit bone degeneration and promote bone formation 
nd it is also medically applied for the treatment of osteoporosis in 
he form of strontium ranelate [ 15 , 16 ]. Zn 2 + is able to stimulate os-
eoblast cell proliferation and differentiation and it also has osteo- 
enesis effects [12] . Mn 2 + influences the regulation of bone remod- 
lling and its deficit causes reduction of organic matrix synthe- 
is and osteogenesis delays, thus increasing the possibility of bone 
nomalies such as decreased bone thickness or length [12] . Cu 2 + is 
ssential in new blood vessels formation and embryonic develop- 
ent, and it is also involved in the generation of reactive oxygen 
pecies (ROS) [ 12 , 17 ]. Li + inhibits the negative regulator of Wnt
Wingless-related integration site denotes genes belonging to the 
NT1/Wingless family) signalling pathway and activates β-catenin- 
edicated T cell factor occurring in bone and cartilage repair [12] . 
o 2 + and Cr 3 + doping have shown positive effects on human mes- 
nchymal stromal cells (hMSCs) proliferation and osteogenic differ- 
ntiation [18] . Co 2 + can increase bone resorbing osteoclast differ- 
ntiation [19] . Ag + is well known for its antimicrobial properties 
gainst large number of bacteria and toxicity against mammalian 
ells [20] . Fe 3 + was reported to promote osteoinduction and new 
one formation, and to be effective in reducing cancer cell popula- 
ion by application of magnetic-filed-induced heating [21] . 
Currently, significant advances on ion-doped brushite cements 
esearch have proved the high interest of these biomaterials to the 
cientific community in bone tissue regeneration/repair. This re- 
iew presents the last six years´achievements in this field. The role 
f ionic substitution on the final cements physicochemical proper- 
ies, namely structure, setting time, hydration products, injectabil- c
2 ty, mechanical behaviour and ion release are discussed ( Table 2 ). 
ell-material interactions, osteogenesis, angiogenesis and antibac- 
erial activity of the doped brushite cements, as well as their po- 
ential as drug/biomolecules carriers are also presented ( Table 3 ). 
Brushite or dicalcium phosphate dihydrate (CaHPO 4 ·2H 2 O, 
CPD) is a very well crystalline mineral phase with CaPs chains ar- 
anged parallel to each other and linked by water molecules ( Fig. 1 
) [44] . The first description of a brushite cement was reported 
y Mirtchi and Lemaitre in 1987 [ 9 ], through the reaction of β- 
CP and MCPM, resulting in the formation of brushite according to 
quation (1) [45] . 
-Ca 3 (PO 4 ) 2 + Ca(H 2 PO 4 ) 2 ·H 2 O + 7 H 2 O → 4 CaHPO 4 ·2H 2 O (1)
The setting reaction starts by the dissolution of the acidic 
CPM in deionized water, which results in a rapid decrease of 
H of the cement paste down to a value of 2.5 [46] . This pH
rop results in an increase of β-TCP dissolution, which is then fol- 
owed by brushite crystallization ( Fig. 1 B). Bohner et al. [47] thor- 
ughly investigated the hydration of brushite cements with vary- 
ng β-TCP/MCPM ratio by isothermal calorimetry. Since they did 
ot detect an endothermic peak at early stages in the calorime- 
ry curves of all systems except for pure MCPM and one with very 
igh MCPM excess, they concluded that the reactions must occur 
imultaneously, resulting in an exothermic peak. This dissolution 
eaction was followed by the exothermic precipitation of brushite 
47] . Detailed investigations of the hydration process of a brushite 
ement during the first seconds and minutes were further reported 
y Luo et al. [48] using in-situ synchrotron powder X-ray diffrac- 
ion (XRD). They observed a four-step process for the initial re- 
ction, described as an initial fast reactant dissolution and nucle- 
tion induction period followed by nucleation of brushite crystals, 
 rapid brushite crystal growth period and a slow growth period, 
here the growth rate of brushite crystals gradually dropped to 
ero. 
Another approach to obtain brushite cements is through the ad- 
ition of phosphoric acid (H 3 PO 4 ) to β-TCP [49] . The reaction pro-
eeds according to Equation (2). 
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Table 2 
The last six years´achievements of the role of dopant ions on the final physicochemical properties of brushite cements, namely on the setting time, injectability, mechanical 
strength and ion release [22-35] . 
Dopant ion in 
brushite cements Setting time Injectability Mechanical properties Ion release 
Ag + Increase of setting time with 
increasing Ag + content, from 3 
min for the reference to 7 min 
for 1.0 wt% Ag + [22] 
Not reported Increase of CS by 30 % for 1 mol% 
[35] ; CS of 4.0 ± 1.0 MPa for 
0.6 wt% Ag + and 1.5 ± 1.0 MPa for 
1wt% Ag + [22] 
Release of 25 μg/L for 0.6 wt% 
Ag + and 43 μg/L for 1.0 wt% 
Ag + [22] 
Mg 2 + IST and FST increased with 
increasing Mg 2 + content. 
FST = 4 min for the undoped 
cement, and 33 min for 
Mg/(Mg + Ca) = 0.1 [24] ; FST 
increased for 13.3 mol% 
Mg 2+ [ 23 ] 
77 % injectability for 
Mg/(Mg + Ca) = 0.1 [24] 
Decreased microhardness for 
contents up to 26.67 mol% [ 23 ]; 
Increased CS for higher contents 
[24] 
Initial burst release for 
26.67 mol% Mg 2 + and low 
release for 66.67 mol% Mg 2 + 
[23] 
Sr 2 + IST and FST increase for Sr 2 + 
concentrations up to 6.6 wt% 
(IST = 21 min and FST = 25 min 
[26] ; Increase of IST for 
Sr 2 + /Mn 2 + co-doped cements 
(5 mol% Sr 2 + ≈5 min; 5 mol% 
Sr 2 + /0.3 mol% Mn 2 + ≈7.2 min; 
5 mol% Sr 2 + /0.7 mol% 
Mn 2 + ≈7 min) [25] 
66% injectability for 6.6 wt% Sr 2 + 
[26] ; Injectability ~4% for 5 mol% 
Sr, and ~97% for 5 mol% Sr 
containing saccharides in the 
setting liquid [25] 
CS increase from 1.32 to 34 MPa 
for 6.6 wt% Sr 2 + content [26] ; High 
strength (CS ≈ 17 MPa) was 
obtained for cement containing 
0.32 mol% Mn and 5 mol% Sr, 
prepared with sucrose as additive 
[25] 
Release of 17.2 % of Sr into 
MG63 culture medium, from 
cements containing 5 mol% Sr 2 + 
[25] 
Zn 2 + Increase of IST and FST for 
0.25 wt% Zn 2 + [32] ; Increase of 
setting time: 7 min for 
undoped sample, 13 min for 
0.6 wt% Zn 2 + and 19 min for 
1.2 wt% Zn 2 + [30] 
The required force for unit 
displacement was higher for 6 wt% 
Zn/15 wt% Si and 9 wt% Zn/15 wt% 
Si, and lower for 3 wt% Zn/15 wt% 
Si (tested in an 
universal testing machine with a 
crosshead of 0.5 mm/min) [34] 
Decrease of CS for 0.25 wt% Zn 2 + 
content [32] 
Release of 0.30 ± 0.01 for 0.6 
wt% and 0.10 ± 0.01 μg/L for 
1.2 wt% content [30] 
Mn 2 + Increase of IST for Sr 2 + /Mn 2 + 
co-doped cements (5 mol% 
Sr 2 + ≈5 min; 5 mol% 
Sr 2 + /0.3 mol% Mn 2 + ≈7.2 min; 
5 mol% Sr 2 + /0.7 mol% 
Mn 2 + ≈7 min) [25] 
Injectability of ~80% for 0.5 and 1 
mol% Mn content, and 100% 
injectability when saccharides 
were incorporated in the setting 
liquid [25] 
High strength (CS ≈ 17 MPa) was 
obtained for cement containing 
0.32 mol% Mn and 5 mol% Sr, 
prepared with sucrose as additive 
[25] ; Decrease of CS with the 
increase of Mn content, from 19.71 
± 2.45 MPa for undoped cements 
and 11.70 ± 1.16 MPa for cements 
containing 30 wt% Mn-TCP [33] 
Higher initial Mn amounts (0.7 
mol%) released a higher Mn 
amount (~0.4 mg g −1 ) [25] 
Co 2 + Decrease of IST = 2.21 ±
0.04 min for 0.3 wt% Co 2 + , and 
increase of IST = 6.80 ±0.08 min 
for 1.2 wt% Co 2 + [28] 
Not reported CS reduction from 3.17 ± 1.04 MPa 
to 1.09 ± 0.21 MPa for 1.2 wt% 
content [28] 
Initial release was up to tenfold 
higher compared to the release 
after 16 days of cultivation. 
Released Co 2 + after 1 day of 
incubation, of 247 ± 26 μM 
[19] 
Cu 2 + Increase of the setting 
time = 50 min for 5% Cu content 
[31] 
88% injectability for 5% Cu [31] Decrease of CS for 50 mmol 
content [18] 
Initial burst release for 10 and 
50 mmol Cu 2 [18] ; Released 
Cu 2 + after 1 day of incubation 
of 305 ± 23 μM, which is 
above the cytotoxic threshold 
for osteoclasts (~30 μM) [19] 
Cr 3 + Not reported Not reported Decrease of CS for 50 mmol 
content [18] 
Very low amount release during 
cell cultivation [19] 
Fe 3 + Increase of setting time up to 
123 min for 5 mol% Fe 2 + [27] 
Not reported High CS for 0.49 wt% Fe 3 + content 
[21] 
Fe released in physiological 
media from 0.49 wt% Fe 3 + , after 
10 days, within the range of 
clinically acceptable Fe blood 
levels [21] 
Si 4 + Increase of FST = 19 min for 
1.1 wt% Si 4 + and no significant 
effect for 0.5 wt% Si 4 + [29] 
The required force for unit 
displacement was higher for 6 wt% 
Zn/15 wt% Si and 9 wt% Zn/15 wt% 
Si, and lower for 3 wt% Zn/15 wt% 
Si (tested in an universal testing 
machine with a crosshead of 0.5 
mm/min) [34] 
CS of 4.32 ±0.63 MPa for 0.5 wt% Si 
content [32] 
SiO 4 
4 − ions release of 33 and 
38 ppm respectively, from 40% 
Si-CPC and 80% Si-CPC, after 3 
days immersion in 
double-distilled water [81] 
CS: compressive strength; FST: final setting time; IST: initial setting time. 
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Table 3 
The last six years´achievements of the role of dopant ions on the final biological properties of brushite cements, namely on cell viability/proliferation, osteoclast activity, 
osteogenesis/angiogenesis, antibacterial studies and its use as drug/biomolecules delivery systems [ 18 , 19 , 21-26 , 28-33 , 35-43 ]. 
Dopant ion in 
brushite cements 
Cell viability and 
proliferation 
Osteoclast activity/in vivo 
biodegradation Osteogenesis /Angiogenesis Antibacterial activity 
Drug/Biomolecules delivery 
systems 
Ag + Low toxicity of human 
adipose-derived stem 
cells growth on 10 mol% 
Ag + [36] 
Not reported Not reported Decrease of S. aureus 
adhesion and an 
inhibitory effect 
towards pathogenic E. 
coli for Ag + amounts 
of 0.6 and 1 wt% 
[ 22 , 35 ] 
Not reported 
Mg 2 + Increased cell 
proliferation in the 
Mg-doped cements in 
comparison without Mg 
[41] 
Progressive degradation 
of the cements after 8 
weeks of implantation in 
rabbits [41] 
New bone formation with 
complete defect filling for all 
compositions, 6.67 % 
Mg-CPC, 26.67 % Mg-CPC 
and 40 % Mg-CPC [41] 
Not reported The drug release was shown to 
be fast for 26.67 mol. % Mg 2 + 
and slow for higher Mg 2 + 
concentrations [41] ; A burst 
release of gentamicin sulfate, 
amoxicillin and ampicillin 
trihydrate in the first 12 hours 
[24] 
Sr 2 + High cell proliferation 
and differentiation for 5 
mol% Sr 2 + [25] 
Not reported Complete filling of bone 
defect for 5 wt% Sr 2 + [37] 
Not reported Increased drug release observed 
in the first 72 hours for 6.6 wt% 
Sr 2 + content, of 96 %, 87 % and 
73 %, respectively for 
gentamicin sulfate, amoxicillin, 
and ampicillin trihydrate [26] 
Zn 2 + High ALP activity in 
MG63 cells [43] 
Osteoclast activity after 
14 days cultivation of 
MG63 cells [43] 
Moderate bone regeneration 
for 0.25 wt. % Zn combined 




towards E. coli for 
0.6 wt% Zn 2 + [30] 
Improved new bone formation 
of IGF-1 loaded 0.25 wt% 
Zn-doped cements [32] 
Mn 2 + High cell proliferation 
and differentiation for 
0.32 mol% Mn 2 + [25] ; 
Inhibition of mBMSCs 
proliferation after 3 days 
culture, for Mn 2 + 
concentration greater 
than 28.21 μg/L [33] 
Not reported Addition of 10 wt% Mn-TCP 
induced the G1 arrest in 
mBMSCs and simulated the 
osteogenesis-related gene 
expression [33] 
Not reported Not reported 
Co 2 + High cell proliferation for 
Co 2 + concentration ≤
50 μM, while 250 μM 
showed reduced cell 
proliferation [18] 
Osteoclast cells detected 
on cements with 10 
mmol Co, after 16 days 
of cultivation [19] 
Not reported Not reported Not reported 
Cu 2 + Dose range of 1 – 2.5 
mg/mL showed positive 
proliferative effect on 
human glial E297, murine 
osteoblastic K7M2 and 
human primary lung 
fibroblasts cells [38] ; 
Cu 2 + concentrations ≤
100 μM resulted in 
enhanced proliferation of 
hMSCs [18] 
After 16 days of 
cultivation, no 
osteoclast-specific 
enzymes TRAP, CAII and 
CTSK, were detected in 
10 mmol Cu 2 + , and Cu 2 + 
at 18 μM completely 
inhibited resorption [19] 
Not reported Antibacterial effects 
against E. coli, P. 
aeruginosa and S. 
enteritidis for Cu 2 + 
content of 0.3 wt% 
[38] ; Larger inhibition 
zones of E. coli , S. 
aureus , and P. 
aeruginos a with 
increasing Cu content, 
and prominent 
inhibition halos 
produced toward P. 
aeruginosa [31] 
Not reported 
Cr 3 + High cell proliferation for 
50 mmol Cr 3 + [18] 
High osteoclast activity 
for 50 mmol Cr 3 + [39] ; 
Osteoclast cells detected 
on cements with 10 
mmol and 50 mmol Cr 3 + , 
after 16 days of 
cultivation [19] 
Osteogenic differentiation 
for 50 mmol Cr 3 + [39] 
Not reported Not reported 
Fe 3 + High cellular activity for 
Fe 3 + content up to 0.50 
wt% [ 21 , 40 ] 
Not reported High levels of osteocalcin 
and Runx2 in MC3T3-E1 
cells for 0.49 wt% and 
1.09 wt% Fe 3 + [21] 
Antibacterials activity 
against E. coli, S. 
enteritidis, P. 
aeruginosa , and S. 
aureus [21] 
Not reported 
Si 4 + High ALP activity in 
MG63 cells [43] 
High TRAP activity for 
0.5 wt% Si 4 + [29] 
Fast neoosseous formation 
and vasculogenesis 
enhancement, for high (0.5, 
0.8, and 1.1 wt%) 
Si 4 + amounts [ 29 , 32 ]; 
Increased angiogenic 
potential [43] 
Not reported Release of 98 % of vancomycin 
in 80 % [Si/(Si + P)] content, after 
168 hours [42] ; Improved new 
bone formation of IGF-1 loaded 
0.5 wt% Si-doped cements [32] 
ALP: alkaline phosphatase; CAII: carbonic anhydrase II; CTSK: cathepsin K; mBMSCs: mouse primary bone marrow-derived mesenchymal stem cells; hMSCs: human mes- 
enchymal stromal cells; IGF: insulin-like growth factor; TRAP: tartrate-resistant acid phosphatase. 
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a 3 (PO 4 ) 2 + H 3 PO 4 + 6H 2 O → 3CaHPO 4 ·2H 2 O (2) 
Regarding a successful clinical application of the cements, sev- 
ral properties need to be considered and carefully adjusted, 
amely the setting time, injectability, dynamic of flow, mechanical 
roperties and the resorption rate. The main important factor is 
he setting time. While hardening needs to be slow enough to give 
he surgeon time for implementation of the cement, a too slow 
ardening time would unnecessarily delay the operation. There- 
ore, the ideal setting time would be in the range of a few min-
tes [50] . Another relevant aspect is the injectability of the ce- 
ent paste for minimal-invasive applications, where the cement 
s directly inserted into the defect through a syringe with narrow 
annulas. Several approaches were developed to improve the in- 
ectability of the cement pastes, namely by adjusting particle sizes 
o a bimodal distribution [51] or using additives, such as citric acid 
 52 , 53 ] or phytic acid [ 54 , 55 ], that alter the zeta potential of the
articles surface and therefore increase the particle repulsion. In 
ddition to their fluidizing effect, sulphate, pyrophosphate, citrate 
nd phytic acid have also been used as retarding agents in brushite 
ements [ 53 , 54 , 56 , 57 ]. For example, Hurle et al. [54] studied the
ffect of phytic acid as a setting regulator, compared with citric 
cid, in brushite cements. An improvement on the injectability and 
n increased reaction delay for higher phytic acid amounts was 
hown. Besides, it was observed that even small phytic acid con- 
entrations were enough to adjust favourable setting and rheology 
erformances. 
The rheological properties have another crucial importance in 
aining understanding of the fundamentals of the dynamics of flow 
f an injectable CPC, through the delivery system (cannula) and its 
ubsequent interdigitating into the trabecular bone [58] . In general, 
PCs are considered viscoelastic materials since they change from 
rimarily liquid-like properties immediately after mixing to pri- 
arily solid-like properties once cured. The mechanical behaviour 
f the cements is of paramount importance, as a compressive 
trength close to 10-12 MPa comparable to that of trabecular bone 5 s required. In general, all factors that influence the injectability 
lso influence the strength of the cements. Thus, the characteris- 
ics of the starting powders, such as particle size, the proportion 
nd nature of the hydrate phases formed, the liquid-to-powder ra- 
io (LPR), and the presence (and/or variation) of additives can sig- 
ificantly change the strength of the materials [59] . 
.1. Ion doping into the structure of β-TCP 
Tricalcium phosphate (TCP) exists in two different modifications 
hat are relevant for application. While α-TCP is stable at temper- 
tures above 1125 °C and can be stabilized at room temperature 
y quenching, β-TCP forms at lower temperatures [60] . The differ- 
nt crystal structures of both phases result in different solubility 
nd hydraulic activity. The α-TCP shows hydraulic activity in its 
rystalline form, while crystalline β-TCP is hardly soluble in wa- 
er [61] . Still, it can be rapidly dissolved in the acidic environment 
f brushite cements, which results in their rapid hardening. 
β-TCP is rhombohedral with the space group R3c. The structure 
an be described as consisting of two different columns aligned 
arallel to the crystallographic c axis [62] . The columns altogether 
ontain five different Ca 2 + positions. The coordination of the Ca 2 + 
on on the five positions with oxygen is sevenfold, eightfold, eight- 
old, fourfold and sixfold, respectively ( Fig. 2 ). While the occupancy 
f the Ca(4) position is 0.43(4), all other positions are fully occu- 
ied [63] . 
In the β-TCP structure, different ions can be incorporated in the 
a 2 + positions. The dopant ions can preferably substitute Ca 2 + on 
ertain atomic positions, depending on their ionic radii for the rel- 
vant coordination with oxygen. 
Mg 2 + was shown to incorporate into the structure of β-TCP up 
o a concentration of 14 mol% preferably occurring on the Ca(5) 
ite [65] . After complete occupation of this site, the Ca(4) site is 
hen occupied. Due to smaller ionic radius of Mg 2 + , compared to 
a 2 + (0.720 and 1.00 Å, respectively, both given for sixfold coor- 
ination [66] ), the incorporation of Mg 2 + results in a decrease of 
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Fig. 2. Schematic representation of the β-TCP structure based on Yoshida et al. [64] . 























he β-TCP lattice parameters a and c ( Fig. 3 A). Substitution of Sr 2 + 
nto the β-TCP structure can occur over a wide range of composi- 
ions [67] . As a result of its higher ionic radius compared to Ca 2 + 
1.18 Å and 1.00 Å, respectively, for sixfold coordination [66] ), an 
ncrease of both parameters is observed ( Fig. 3 B). 
Different studies were reported dealing with the incorporation 
f Cu 2 + into β-TCP. While these studies agreed that Cu 2 + mainly 
ccupies the Ca(5) position in the β-TCP structure, the data differ 
n their reported substitution limits. Nord [69] reported a substi- 
ution limit of 12 mol%. In contrast, Matsumoto et al. [70] set the 
imit for Cu 2 + incorporation of 9.09 mol% for β-TCP co-doped with 
g + and Cu 2 + . This substitution limit reached a full occupancy of 6 he Ca(5) positions by Cu 2 + , while the Ag + fully occupies the Ca(4) 
osition up to a limit of 9.09 mol%. A recent study by Spaeth et al.
71] proposed an incorporation limit between 14 and 15 mol% Cu 2 + 
n the structure of β-TCP, as a Cu 2 + containing secondary phase 
tarted to form at a content of 15 mol%. Furthermore, a clear de- 
rease of both lattice parameters a and c with increasing Cu 2 + con- 
ent was observed (ionic radius for Cu 2 + : 0.73 Å, for sixfold coor- 
ination [66] ) ( Fig. 4 A). 
Different authors have found that the substitution limit for Ag + 
n β-TCP is in the range of 8 - 10 mol%, as the secondary phase
g 3 PO 4 was reported for 10 mol% Ag 
+ content [ 73 , 74 ]. This sub-
titution resulted in a decrease of the c parameter, while the a pa- 
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p 4 ameter remained constant. They further suggested that the substi- 
ution occurred by replacing one vacancy and one Ca 2 + ion at the 
a(4) position by two Ag + ions, but with no proof of this theory. 
Similarly, different substitutions of Zn 2 + are reported. Mat- 
umoto et al. [70] showed a limit of 9.09 mol% Zn 2 + , which was in-
orporated at the Ca(5) position. In contrast, Gomes et al. [75] pro- 
osed the substitution at both Ca(4) and Ca(5) position, which re- 
ulted in a substitution limit of 13.6 mol% Zn 2 + [64] . In accordance 
o Mg 2 + and Cu 2 + , Zn 2 + incorporation (Zn 2 + ionic radius: 0.740 Å, 
or sixfold coordination [66] ) results in a reduction of both the a 
nd c parameter ( Fig. 4 B). 
.2. Physicochemical properties of ion-doped brushite cements 
.2.1. Setting time / setting reaction 
Ionic dopants move to the mixing liquid upon dissolution of 
he CPCs and can thus significantly influence the setting time 
 36 , 40 , 76 ]. Owing to its importance for the clinical application, the
etting time needs to be fully investigated for the development 
f functional brushite cement formulations incorporating dopants 
ons. 
The Mg 2 + role on the setting behaviour of a brushite cement 
as studied by several authors. Saleh et al. [24] studied the set- 
ing of brushite cements composed of MCPM and β-TCP doped 
ith different Mg 2 + concentrations (Mg/(Mg + Ca) molar ratios of 0, 
.025, 0.05, 0.075 and 0.1). They showed that both initial (IST) and 
nal setting time (FST) were remarkably increased with increas- 
ng Mg 2 + content. FST was 4 min for the undoped cement and 
ncreased up to 33 min for the sample with Mg/(Mg + Ca) = 0.1. 
lkhraisat et al. [23] investigated cements containing monocal- 
ium phosphate (MCP) and powders with a Mg/(Mg + Ca) molar ra- 
io up to 66.67% composed of Mg 2 + -substituted β-TCP, stanfield- 
te (Ca 4 Mg 5 (PO 4 ) 6 ) and/or farringtonite (Mg 3 (PO 4 ) 2 ). In the same
anner, Saleh et al. [24] observed an increase of FST by Mg 2 + in- 
orporation up to 13.3 mol%. The setting time decreased for higher 
g 2 + concentrations, attributed to the formation of newberyite 
MgHPO 4 ·3H 2 O) in addition to brushite. 
Taha et al. [26] analyzed brushite cements composed of β- 
CP doped with different Sr 2 + concentrations (0, 2.4, 6.6, 7.4 and 
.9 wt%) and MCPM. They observed a significant increase of both 
ST and FST for Sr 2 + concentrations up to 6.6 wt% (IST: 2 min 
or reference, 21 min for 6.6 wt% Sr 2 + ; FST: 4 min for reference,
5 min for 6.6 wt% Sr 2 + ). The setting times decreased for higher 7 r 2 + concentrations due to monetite formation, but still above the 
alues obtained for the undoped samples. 
The setting of brushite cements containing β-TCP co-doped 
ith Mn 2 + and Sr 2 + (Sr 2 + concentration: 5 mol%; Mn 2 + concen- 
ration: 0, 0.3 and 0.7 mol%) was investigated by Torres et al. 
25] . They observed an increase of IST for both Sr 2 + -doped and 
r 2 + /Mn 2 + co-doped samples, being more pronounced for the co- 
oped samples (reference ≈ 2.8 min; 5 mol% Sr 2 + ≈ 5 min; 5 mol% 
r 2 + + 0.3 mol% Mn 2 + ≈ 7.2 min; 5 mol% Sr 2 + + 0.7 mol% Mn 2 + 
7 min). An increase by a factor of more than 2.5 was observed 
or the samples containing 5 mol% Sr 2 + and 0.7 mol% Mn 2 + , com- 
ared to the undoped reference. This was explained by a synergis- 
ic effect resulting from the presence of both ions, leading to the 
nhancement of the chemical stability towards the setting liquid. 
Similarly, an increase of the setting time was reported for 
rushite cement composed of Fe 2 + doped β-TCP and MCPM with 
he addition of 1 wt% chitosan by Li et al. [27] . The setting time
ncreased with increasing Fe 2 + concentration up to 123 min for 
 mol% Fe 2 + , which was about tenfold compared to the reference 
12 min). Furthermore, a decrease of conversion rate after 72 h of 
etting was indicated by the decrease of brushite reflection inten- 
ities with increasing Fe 2 + content, accompanied by an increase of 
esidual MCPM reflection intensities. Ca 19 Fe 2 (PO 4 ) 14 was addition- 
lly detected in samples with higher iron content. While no char- 
cterization of the starting powder was reported [27] , it is logical 
o assume that this compound was already present in the starting 
owder [27] . This assumption is supported by the observations of 
skokovic et al. [21] , who reported the formation of the similar 
ompound Ca 9 Fe(PO 4 ) 7 and small amounts of hematite in β-TCP 
tarting powders doped with 0.49 and 1.09 wt% Fe. Although the 
ffect of Fe 3 + on the setting time was not reported in this study, 
s the setting reaction was only investigated by Energy Dispersive 
-Ray Diffraction (EDXRD) for one Fe 3 + concentration, the authors 
tated that the cement setting was relatively fast. 
Vahabzadeh et al. [28] investigated brushite cements containing 
-TCP doped with variable Co 2 + contents (0, 0.3, 0.5 and 1.2 wt%). 
hile the IST of the samples containing 0.3 wt% Co 2 + decreased 
rom 3.67 ± 0.23 min (reference) to 2.21 ± 0.04 min, it increased 
o 6.80 ± 0.08 min for 1.2 wt% Co 2 + . The increase of setting time 
or higher Co 2 + concentrations was attributed to a stabilization of 
he β-TCP structure by incorporation of the smaller Co 2 + ion com- 
ared to Ca 2 + , resulting in reduced solubility, whereas the decrease 
f setting time observed for 0.3 wt% Co 2 + was attributed to the 
ossible formation of CoHPO with high solubility. Cummings et al. 
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Fig. 5. Dependence of the hydration products crystallite size and Ca 2 + content on 












































77] reported a reduction of brushite formation with increasing 
o 2 + content on brushite cements containing β-TCP doped with 
.25, 0.5 and 1 wt% Co 2 + (no secondary phases detected). This 
act was attributed to the reduction of β-TCP solubility by lattice 
hrinkage induced by the smaller Co 2 + ion [28] . 
Vahabzadeh et al. [29] investigated the setting of brushite ce- 
ents containing β-TCP doped with 1.1 wt% Si 4 + . No impact of 
i 4 + on the IST was observed, and the FST was significantly in- 
reased from 11-12 min (undoped reference) to 19 min. Further- 
ore, no significant effect of Si 4 + on the setting time of brushite 
ements containing β-TCP doped with 0.5 wt% Si 4 + , 0.25 wt% Zn 2 + 
r co-doped with 0.5 wt% Si 4 + / 0.25 wt% Zn 2 + was reported [32] .
n the other hand, the addition of Zn 2 + led to a significant in- 
rease of the IST and FST, attributed to the stabilization of the β- 
CP structure by Zn 2 + , which retards β-TCP dissolution. The setting 
imes of brushite cements with Zn 2 + -doped β-TCP were also in- 
estigated by Graziani et al [30] . They observed an increase of the 
etting time with increment of Zn 2 + content (7 min for undoped 
ample, 13 min for 0.6 wt% Zn 2 + and 19 min for 1.2 wt% Zn 2 + ).
he setting delay was explained by the formation of CaZn 2 (PO 4 ) 2 
etected by in-situ time resolved EDXRD measurements, which can 
inder brushite crystal growth. In accordance, a lower conversion 
ate was observed for the Zn 2 + containing samples. 
Ag + did not show any effect on the setting time of a brushite 
ement composed of β-TCP doped with 1 mol% Ag + and monocal- 
ium phosphate anhydrate [35] . Contrary to this, Rau et al. [22] ob- 
erved an increase of cement setting time with increasing Ag + 
ontent from 3 min for the reference to 7 min for an Ag + con-
ent of 1.0 wt%. The cements were obtained by adding magne- 
ium dihydrogen phosphate tetrahydrate with phosphoric acid and 
0 wt% glycerol solution with a LPR of 3/4 mL/g. The increased 
etting time was accompanied by a lower conversion rate for both 
amples doped with Ag + (0.6 and 1.0 wt% Ag + content). While in 
35] no secondary phases were detected in the Ag-doped TCP, in 
22] metallic Ag + was detected as secondary phase after sintering 
he precipitated powders at 1300 °C. 
It has to be taken into account that all single data presented 
bove cannot be directly compared with each other. Dissolution 
ates and consequently setting times in practice are also quite 
ependent from synthesis temperature, particle fineness, possible 
urther cement additives and LPR. 
.2.2. Hydration products of brushite cements 
Ionic dopants have the potential to affect not only the hydra- 
ion kinetics, but also the hydrate phases which precipitate dur- 
ng hardening. The dopants can be incorporated into the crystal 
tructure of the hydrate phases and alter their crystal morphol- 
gy. These parameters can then in turn affect the biological per- 
ormance of the hardened cement. 
Li et al. [27] observed larger brushite crystal particles for ce- 
ents incorporating different concentrations up to 5 mol% of Fe 2 + , 
hich effect appeared to be independent on the Fe 2 + content. 
hile a decrease of brushite XRD peak intensity was reported, no 
nformation about the development of the lattice parameters was 
rovided. Indeed, indications for Fe 3 + substitution in brushite were 
eported by Uskokovic et al. [21] by peak shifts in the correspond- 
ng XRD time resolved in-situ spectra in comparison to the refer- 
nce. In contrast to this, no peak shift was recorded for brushite 
anoparticles doped with different Fe 3+ contents [78] . Still, it was 
bserved an increase of crystallite size determined according to 
herrer ́s equation with increasing Fe content from 23 to 74 nm 
 Fig. 5 ). 
Schamel et al. [18] observed no effect of 50 mmol Co 2 + or Cu 2 + 
oped β-TCP on the morphology of brushite. They presented plate- 
ike crystals for both ions, as well as for the undoped reference. In 
ontrast, an effect of doping β-TCP with 50 mmol Cr 3 + was noticed 8  Fig. 6 ). Here, agglomerates of small particles in the dimension of 
he crystals in the other cements were observed. This was accom- 
anied by a change of phase composition. While slight amounts of 
onetite (CaHPO 4 ) were formed in addition to brushite in all sam- 
les, its content was remarkably higher in the sample containing 
0 mmol Cr 3 + . 
Co-doping with Si 4 + and Zn 2 + can change the brushite crystal 
orphology from a compact structure (in the undoped cements) to 
ndividual needle/plate-like crystals in the cements doped with dif- 
erent ions concentration (0.5 wt% Si 4 + , 0.25 wt% Zn 2 + or 0.5 wt% 
i 4 + / 0.25 wt% Zn 2 + ), whereas maintaining the qualitative phase 
omposition [32] . Vahabzadeh et al. [29] observed no effect on the 
hase composition of the hydrated cement by adding 1.1 wt% Si 4 + , 
s only remaining β-TCP and brushite were present. In the study 
f Graziani et al. [30] , a clear effect of Zn 2 + doping on phase trans-
ormations was observed. While in the undoped reference, brushite 
nd residual β-TCP were present after hardening, only monetite 
as detected in the cements doped with 1.2 wt% Zn 2 + as hy- 
ration product. Furthermore, CaZn 2 (PO 4 ) 2 was detected in both 
n 2 + containing samples (0.6 and 1.2 wt%). Though the authors 
laimed that this phase was absent in the starting powders, it ap- 
ears unlikely that this non hydrated phase really formed by pre- 
ipitation from solution after the mixing liquid addition. Instead, 
aZn 2 (PO 4 ) 2 ·2H 2 O is formed by precipitation from solution, thus 
equiring a thermal treatment to remove the structural water and 
o obtain CaZn 2 (PO 4 ) 2 [79] . It is therefore more plausible that the 
hase was already present in the starting powders, but not de- 
ected, and remained unreacted during hydration. 
Co-doping with Mn 2 + and Sr 2 + (Sr 2 + concentration: 5 mol%; 
n 2 + concentration: 0, 0.3 and 0.7 mol%) had nearly no effect 
n qualitative phase composition [25] . In contrast, Taha et al. 
26] found that Sr 2 + favored the formation of monetite, which ap- 
eared as main hydration product for higher Sr 2 + contents (7.4 and 
.9 wt%). The observed increase of the brushite lattice parameters 
as indicative of Sr 2 + incorporation for the cements with lower 
r 2 + concentrations, while additionally a distortion of the struc- 
ure of brushite and monetite was evidenced by Fourier Trans- 
orm Infrared (FTIR). Furthermore, the authors described a change 
rom small structured particles of irregular morphology to loosely 
acked plate-like morphology with heterogeneous size distribution 
y Sr 2 + incorporation. 
No influence of 1 mol% Ag + doping on brushite crystal mor- 
hology or on its diffraction pattern was observed in [35] . In 1 wt%
g + -doped cement studied by Rau et al. [22] , the formation of 
ivalent calcium-silver polyphosphate CaAg(PO 3 ) 3 was claimed in 
ddition to brushite formation, since this phase was not detected 
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Fig. 6. Microstructure of brushite fractured surfaces obtained by scanning electron microscopy: brushite reference (Ref) and cements doped with 10 mmol Cu 2 + (Cu 10), 50 






























































n the starting powders, but in the hydrating cement pastes. The 
eaks resulting from metallic Ag, which was claimed to be present 
n the starting powders, were not detected. While these observa- 
ions indicated a reaction of metallic Ag with Ca 2 + and PO 4 3 − ions 
n solution, resulting in the formation of CaAg(PO 3 ) 3 , this appears 
hemically implausible. The authors did not present any theory or 
roposed reaction scheme to explain their observations. The mor- 
hology of the cements was not noticeably affected by the Ag + ad- 
ition and the brushite was present in the typical plate-like shape 
22] . 
A clear effect on brushite crystal morphology was also observed 
or Se 4 + incorporated into brushite synthesized via wet precipita- 
ion method in a concentration of 0.67 wt% [80] . Plate-like crys- 
als with a diameter and length of around 10 μm and 20–30 μm, 
espectively were obtained for the undoped reference, while the 
orphology changed to rod-like crystals with a diameter of 5–
 μm and length higher than 25 μm for Se 4 + -doped samples. Fur- 
hermore, Se 4 + incorporation into the brushite lattice was indi- 
ated by change of the lattice parameters, namely a significant in- 
rease of a parameter and simultaneous decrease of c parameter. 
urthermore, the substitution of phosphate by selenite SeO 3 
2 − was 
onfirmed by solid state 1 H → 31 P cross-polarization combined 
ith magic-angle spinning (CP MAS) kinetics experiments. 
Additional phases can be already present in the β-TCP starting 
aterial, if a higher amount of the respective dopant is present. 
hese phases might then react to form hydrate phases other than 
onetite and brushite. For example, the starting powder of the 
g 2 + modified cements investigated by Alkhraisat et al. [23] con- 
ained stanfieldite and / or farringtonite in addition to Mg 2 + -doped 
-TCP. Consequently, the magnesium phosphate hydrate phase 
ewberyite (MgHPO 4 ·3H 2 O) was formed in addition to brushite at 
igher Mg 2 + contents. Besides, indications of 3 mol% Mg 2 + incor- 9 oration into the structure of brushite were found by application 
f selected-area electron diffraction (SAED) and Energy Dispersive 
-Ray (EDX). Still, no clear tendency of brushite lattice param- 
ters with increasing Mg 2 + content was observed. Similarly, the 
ncorporation of Mg 2 + into the brushite structure was indicated 
y a shift of the XRD peaks, being more pronounced for higher 
g 2 + contents [24] . However, since no refined lattice parameters 
ere reported for brushite, it cannot be excluded that the observed 
eak shifts might also result from preparation-related effects. Ad- 
itionally, the broadening of the FTIR signals representative of the 
rushite cements (a detailed overview of the brushite IR vibration 
odes is elsewhere reported [24] ) was noticed, which is indicative 
f the lattice distortion induced by Mg 2 + incorporation. Mg 2 + was 
urther shown to favor the formation of larger-sized particles as 
ake- or needle-like, while an irregular morphology was present 
n the cements without Mg 2 + [24] . Newberyite formation in addi- 
ion to brushite was also observed in the cement system investi- 
ated by Cabrejos-Azama [41] , which contained starting powders 
ith molar Mg/(Mg + Ca) ratios between 26.67 and 66.67%. 
Aparicio et al. [81] developed brushite cements containing Si 4 + - 
oped β-TCP with Si 4 + contents up to 80 mol% Si/(Si + P). It was
hown that the phase composition of the hydrated cement was 
trongly dependent on the Si 4 + content. Brushite was present in 
ll samples (mainly in those with Si 4 + contents up to 60 mol%) 
nd silicocarnotite (Ca 5 (PO 4 ) 2 SiO 4 ) in the doped samples, while 
he sample with the highest Si 4 + content was mainly composed 
f an amorphous phase. No XRD analyses of the sintered powders 
ere reported, but for logical reasons it can be assumed that the 
ilicocarnotite was not formed during hydration, but was already 
resent in the sintered starting powders. Furthermore, HAp was 
resent as hydration product in the Si 4 + containing samples. Ce- 
ent morphology was affected by the Si 4 + content by observing 
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Fig. 7. Influence of ionic doping with Mg 2 + (A) [24] and Sr 2 + (B) [26] on the injectability of a brushite cement. Injectability tests were performed by placing the cement 
paste into a 10 mL syringe (2 mm diameter aperture; 13 mm diameter cartridge), and then mounting a compressive load (5 kg) on top of the plunger to start injection, until 
the paste was no longer injectable. The percentage of injectability was determined by the ratio between the mass of the paste that could be expelled from the syringe and 




































































late-like crystals in the reference and in the cements contain- 
ng 20 mol% Si 4 + , and additional sphere-like crystals in the ce- 
ents containing 20 mol% Si 4 + . A more rounded morphology was 
bserved with increasing Si 4 + content, while tube-like structures 
omposed of rounded nanocrystals appeared for 60 and 80 mol% 
i 4 + . 
.2.3. Injectability 
As aforementioned, several organic additives have already been 
nvestigated to improve the brushite cement injectability. How- 
ver, injectability can also be affected by dopant ions. Saleh et al. 
24] observed a strong improvement of the injectability of brushite 
ement by Mg 2 + addition ( Fig. 7 A). Up to 77% injectability was 
eported for a Mg 2 + content of Mg/(Mg + Ca) = 0.1, compared to 
nly 10 % injectability obtained for the reference. The enhanced 
njectability was related to an increased setting time. 
A similar effect was observed for cements co-doped with Mn 2 + 
nd Sr 2 + (Sr 2 + concentration: 5 mol%; Mn 2 + concentration: 0, 0.3 
nd 0.7 mol%) [25] . In this case, the injectability of the cements 
oped with 0.7 mol% Mn 2 + was slightly lower than that with 
.3 mol% Mn 2 + when an aqueous solution containing 15 wt% cit- 
ic acid, 10 wt% poly(ethylene glycol) and 0.5 wt% hydroxyl propyl 
ethylcellulose was used as a mixing liquid. Only a marginal in- 
rease of the injectability was observed for doping the cements 
ith Sr 2 + alone, by using mixing liquids containing sucrose or 
ructose. The reference was not injectable at all for all mixing liq- 
ids. Taha et al. [26] reported an increase of the injectability by 
r 2 + doping, up to 66% for 6.6 wt% Sr 2 + ( Fig. 7 B), which was also
elated to an increase of the setting time. For higher concentra- 
ions, the injectability decreased again, in accordance with a de- 
rease in setting time, related to monetite formation. 
.2.4. Mechanical properties 
The mechanical properties of hardened bone cements are rele- 
ant, especially when it comes to load-bearing applications. Some 
pproaches towards the improvement of the strength of brushite 
ements have been developed, such as fiber reinforcement [82] , or 
tilizing the reinforcing effect of residual β-TCP particles [83] . Fur- 10 hermore, it has to be considered that ionic dopants can have a 
ositive or negative impact on the mechanical properties. 
Alkhraisat et al. [23] observed a decrease of diametral tensile 
trength of Mg 2 + containing brushite cement for lower Mg 2 + con- 
ents up to 26.67 mol%, which according to the authors might have 
esulted from reduced microhardness of the brushite due to crystal 
efects. The strength recovered for higher Mg 2 + contents, proba- 
ly due to the formation of newberyite (MgHPO 4 ·3H 2 O), which led 
o a denser cement matrix. Saleh et al. [24] observed an increase 
f compressive strength (CS) with increasing Mg 2 + content. A CS 
f only 1.32 MPa was obtained for the reference, while it strongly 
ncreased up to 20.98 MPa for a cement with a Mg 2 + content of 
g/(Mg + Ca) = 0.1. This effect was explained by the reduced poros- 
ty of the Mg 2 + -doped cements. 
Cement containing β-TCP doped with 1 mol% Ag + showed an 
ncrease of the CS by 30 % in the study reported by Ewald et al.
35] . In contrast, a reduction of CS by Ag + addition was observed 
y Rau et al. [22] . CS was reduced to 4.0 ± 1.0 MPa (0.6 wt% Ag + )
nd 1.5 ± 1.0 MPa (1 wt% Ag + ), while CS of 6.5 ± 1.0 MPa was ob-
ained for the reference. The different behavior observed in those 
wo studies might be explained by the formation of CaAg(PO 3 ) 3 
22] , with no secondary phases detected [35] . 
Fe 3 + was reported to have a positive impact on the CS of 
rushite cements [21] . The CS was more than doubled by doping 
-TCP with 0.5 wt% Fe 3 + after 1 day of hardening [21] . This was
xplained by the presence of small-sized brushite crystals, result- 
ng in a reduction of porosity. 
Co-doping with Mn 2 + and Sr 2 + was seen to be beneficial with 
espect to CS. The highest CS was obtained for β-TCP containing 
 mol% Sr 2 + and 0.32 mol% Mn 2 + . While the CS decreased for ce- 
ents with 5 mol% Sr 2 + and 0.7 mol% Mn 2 + , it was still above the
alue obtained for the cements doped with 5 mol% Sr 2 + only [25] . 
he improved CS was explained by the reduced porosity of the 
ardened cement. As no reference without Sr 2 + was investigated 
ith respect to CS in this study, the effect of Sr 2 + alone was not 
etermined. Still, Taha et al. [26] observed a remarkable increase of 
S from 1.32 to 34 MPa for adding 6.6 wt% Sr 2 + into β-TCP, while
he CS decreased for higher concentrations. 
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In contrast, other ions were reported to have a negative im- 
act on CS. Addition of 1.2 wt% Co 2 + reduced the CS from 3.17 ±
.04 MPa to 1.09 ± 0.21 MPa, being less pronounced for lower Co 2 + 
oncentrations [28] . Reduction of CS was further observed in ce- 
ents containing β-TCP with 10 and 50 mmol of Co 2 + [18] . Cu 2 + 
nd Cr 3 + were reported to decrease the CS when added in con- 
entrations of 50 mmol, while a concentration of 10 mmol had no 
oticeable effect [18] . 
Vahabzadeh et al. [29] observed a slight increase of CS on the 
ements containing 1.1 wt% Si 4 + , from 4.78 ± 0.21 MPa to 5.53 ±
.53 MPa, while lower Si 4 + concentrations did not have any sig- 
ificant effect. In another study, the cements ́CS was reported not 
o be affected by the addition of 0.5 wt% Si 4 + , while addition of
.25 wt% Zn 2 + resulted in a decrease of CS [32] . 
.2.5. Ion release from brushite cements 
In order to assess the biological impact of dopant ions into 
rushite cements, it is highly relevant to understand how they are 
eleased from the cement to the surrounding liquid, as they can 
nly be effective there. In addition to the release performance of 
he dopant ion, its effect on the release of Ca 2 + and phosphate ions 
an also be of biological relevance. The release profile of the corre- 
ponding ions can be dependent on the ion type, as well as on the 
ements composition. 
In the cements investigated by Alkhraisat et al. [23] , the sam- 
le containing 26.67 mol% Mg 2 + showed an initial burst release of 
a 2 + and Mg 2 + , while a low constant release of both ions occurred 
or 66.67 mol% Mg 2 + . Saleh et al. [24] observed a significant in- 
rease of the cation release after 7 days due to Mg 2 + incorporation, 
specially for the highest Mg 2 + concentration (Mg/(Mg + Ca) = 0.1). 
his was explained by a lower degree of crystallinity of the Mg 2 + - 
oped cement. 
Ewald et al. [35] reported a dependence of Ag + release on the 
urrounding medium. The Ag + release was low for PBS, whereas 
t was remarkably higher in lysogeny broth. The release level was 
ore or less constant during 7 days, in the range of approximately 
5–30 μg. Rau et al. [22] observed a release of 25 μg/L and 43 μg/L,
espectively for 0.6 and 1.0 wt% Ag + content in β-TCP, in TRIS-HCl 
uffer solution at 37 °C. As a solid to liquid ratio of 0.5 g / 100 mL
as applied for the insertion of crushed cement into the solution, 
his corresponded to a release of 5 μg/L and 8.6 μg/L respectively, 
or 0.6 and 1.0 wt% Ag + content in β-TCP, from 1 g of cement. A
lateau, indicative of equilibrium, was reached after 15 days. Thus, 
he ion release was below the concentrations expected to be toxic, 
.e. 100 μg/L in the blood [84] . 
The release of Fe 3 + from a brushite cement determined at 37 
C in TRIS-HCl buffer solution at pH = 7.4 was 0.313 ± 0.003 mg/mL 
15.7 mg Fe 3 + released from 1 g of crushed cement with the ap- 
lied solid to liquid ratio of 1 g / 100 mL) and therefore, one order
f magnitude lower than the toxicity level [21] . 
Schamel et al. [18] detected an initial burst release of Cu 2 + 
or samples containing either 10 or 50 mmol Cu 2 + , followed by 
 lower constant release. This burst release was attributed to the 
ossible presence of CuHPO 4 , which has a high solubility compa- 
able to brushite. Having a rhombohedral structure, this crystalline 
hase is not isostructural to the triclinic monetite (CaHPO 4 ) [85] . 
urthermore, a reduction of phosphate release was observed by 
u 2 + addition. A comparable observation was made for Co 2 + in the 
ame study, where the burst release was explained by the highly 
oluble CoHPO 4 . In contrast to this, a continuously low release rate 
as observed for Cr 3 + , which was explained by the low solubility 
f chromium phosphate. Furthermore, phosphate release was re- 
uced in the samples containing 50 mmol Cr 3 + . 
For Zn 2 + -doped cement, releases of 0.30 ± 0.01 and 0.10 ±
.01 μg/L were observed for contents of 0.6 and 1.2 wt% Zn 2 + , re-
pectively, in TRIS-HCl buffer at pH = 7.4 [30] . A solid to liquid ratio11 f 0.5 g / 100 mL yielded releases of 0.060 μg/L and 0.020 μg/L 
n 2 + , respectively for 0.6 and 1.2 wt% Zn 2 + and 1 g of brushite ce-
ent. The lower release obtained for higher dopant concentrations 
as attributed to the decrease of the dissolution rate of Zn-doped 
CP. Torres et al. [25] reported a decrease of Sr 2 + release in Sr 2 + 
nd Mn 2 + co-doped β-TCP cements. Furthermore, they observed a 
referential leaking of the Mn 2 + ion. Generally, the Mn 2 + release 
as higher for cements containing higher ion concentration. 
Aparicio et al. [81] noticed a strong ions release effect of Si 4 + 
oping. An initial burst release of 1155 and 990 ppm for Ca 2 + 
nd phosphate, respectively, followed by a continuous release, was 
bserved for the undoped cements after 7 days of immersion in 
ouble-distilled water. In the cements 40 % Si-CPC and 80 % Si- 
PC, a release of SiO 4 
4 − ions of 33 and 38 ppm was observed after 
 days of incubation. For Se-doped brushite, a higher release rate 
as observed for Se 4 + , compared to Ca 2 + and phosphate, which 
as explained by the possible adsorption of selenite ions on the 
urface of brushite crystals [80] . 
.3. Biological performance of ion-doped brushite cements 
.3.1. Cell growth, viability and proliferation 
The viability and proliferative behaviours are directly dependent 
n the nature and amount of dopant ions in the materials [36] . 
hile some ions have the potential to promote cell viability, oth- 
rs can have toxic effects on cells if they are added in too high 
oncentrations. In order to avoid these toxic effects, it is highly 
elevant to assess the concentration-dependent influence of each 
opant ion on cell growth and viability. 
A positive proliferative effect of Cu 2 + on human glial E297, 
urine osteoblastic K7M2 and especially, human primary lung fi- 
roblasts cells, can be found in the 1 – 2.5 mg/mL dose range (16 
39 mM) [38] . Likewise, Schamel et al. [18] did not find any nega-
ive effects on hMSCs proliferation performed for Cu 2 + concentra- 
ions ≤ 100 μM, while 250 μM resulted in a decrease of the cell 
umber after day 7 and a concentration of 500 μM even led to 
ell death after 7 days ( Fig. 8 A). For Co 2 + , cell proliferation was
ot negatively affected up to a concentration ≤ 50 μM. 250 μM 
ed to a significantly reduced cell proliferation, whereas 500 μM 
aused a continuous decrease of cell number. No negative impact 
n cell proliferation was observed for Cr 3 + up to 250 μM, and only 
t 500 μM, the cell number was significantly reduced [18] . In direct 
ell culture, no cells were detected on Co50 and only small number 
f cells on Co10 ( Fig. 8 B). For Cr 3 + , a proliferation higher or sim-
lar to the reference was observed for 50 mmol concentration in 
ndirect culture, while proliferation was diminished for 10 mmol 
r 3 + . This was attributed to a decrease of Ca 2 + level measured 
or 10 mmol Cr 3 + . In direct culture, an enhanced cell proliferation 
ompared to reference was observed for Cr 3 + doped cement, espe- 
ially for 50 mmol Cr 3 + . Still, the authors explained that this effect 
ight also result from the altered cement morphology observed 
or this sample. 
In another study from Cummings et al. [77] , no effects of MG- 
3 cell growth on brushite cements by different Co 2 + concentra- 
ions up to 1 wt% doped into the β-TCP content was noticed. Ag + -
ubstituted brushite showed low toxicity when cultured with hu- 
an adipose-derived stem cells (ADSCs) up to 10 mol% Ag [36] . 
In the case of doping brushite cements with Fe, a high cellular 
ctivity was observed for Fe concentration up to 0.50 wt%, while 
 higher concentration of ~1.00 wt% resulted in adverse effects on 
ell morphology and proliferation [ 21 , 40 ]. 
Multiple advantages on proliferation and osteogenic differentia- 
ion were also observed with Sr 2 + and low concentration of Mn 2 + 
 25 , 33 ]. For example, Sr 2 + and Mn 2 + co-doped brushite cements 
ultured on human MG63 osteoblastic cells have shown the best 
roliferation and differentiation results obtained for cements con- 
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Fig. 8. Viability of hMSCs after 1 and 21 days of culture: A) in the presence of Cu 2 + (A), Co 2 + (B) and Cr 3 + (C) added to the cell culture medium using different concentrations, 





















aining 5 mol% Sr 2 + only or 5 mol% Sr 2 + and 0.32 mol% Mn 2 + [25] .
ccordingly, the highest cell density was observed on the surface 
f discs with 5 mol% Sr 2 + and 0.32 mol% Mn 2 + , showing better 
preading and adherence of the cells to the substrate. It was fur- 
her reported that the cell viability of MG63 pre-osteoblastic cells 
as increased by addition of Sr 2 + for all Sr 2 + concentrations inves- 
igated. 
An enhancement of cell proliferation was detected for adding 
i 4 + in high concentrations. A more than threefold enhancement 
as reported for 80 mol% Si 4 + , attributed to the ion release [81] .
urthermore, an enhancement of cellular adhesion induced by Si 4 + 
as observed. In contrast, a higher cytotoxicity was observed for o
12 e-doped brushite, compared to the reference, which corresponds 
o the release kinetics. The toxicity decreased with increase of di- 
ution fold [80] . 
An interesting approach to obtain a ZrSi-doped brushite cement 
as reported by substituting the precursor β-TCP with baghdadite 
Ca 3 ZrSi 2 O 9 ). This resulted in cements with enhanced proliferation 
ctivity of primary human osteoblast, with very low effect on the 
echanical properties for up to 50 wt% substitution, and a strong 
eduction in phosphate release [86] . 
.3.2. Osteoclast activity / in vivo biodegradation 
Considering that brushite cements can be resorbed by physic- 
chemical dissolution in the body, osteoclast activity can still play 
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Fig. 9. Cr 3 + -doped brushite cements explants: I) Radiographic analysis after 6 months of implantation in rat tibia (A) and material resorption after 3 and 6 months of 
implantation (B); ∗∗p < 0.01, ∗∗∗p < 0.001; II) Micro-CT analysis of the defect area after 6 months of implantation (A); Sagittal section plane (B), and Material resorption after 
















































n additional role in the biodegradation of these type of materials 
10] . Furthermore, the presence of ionic dopants has shown im- 
ortant effects on the biodegradation and consequently on bone 
ormation [ 36 , 40 , 43 ]. For example, Si 4 + was reported to increase
he activity of osteoclast like cells, while the amount of Si 4 + 
oping did not affect the RAW 264.7 monocyte adhesion [29] . 
ll Si 4 + doped brushite cements showed higher tartrate resis- 
ant acid phosphatase (TRAP) activity compared with undoped 
rushite cements, which signified the enhancement of osteoclas- 
ogenesis by Si 4 + doping. An amount of 0.5 wt% Si 4 + addition 
ppeared to be the optimum with respect to osteoclast-like-cell 
ifferentiation. 
Another study by Rentsch et al. [39] showed an increase of os- 
eoclast activity after 3 and 6 months of implanting brushite sam- 
les doped with 10 and 50 mmol Cr 3 + in proximal tibia bone de- 
ects in rats, being more pronounced for higher Cr 3 + concentration 
 Fig. 9 ). This also resulted in a higher resorption rate, supported by 
he higher resorbability of the Cr 3 + doped material. They further 
bserved a significant increase of the in vivo degradation of the 
aterials by Cr 3 + addition, with only 53% detected after 6 months 
f implantation ( Fig. 9 I). Moreover, a decrease of Cr 3 + content in 
he implanted material from 3 to 6 months was observed, with 
pproximately 40% material remaining in the implantation site, af- 
er 6 months of implantation ( Fig. 9 II). The release of Cr 3 + re-
ulted in positive effects on cement degradation, osteoclasts activ- 13 ty and new bone formation. The significant resorption of the ce- 
ents can also be attributed to the use of phytic acid as setting 
etarder, which influences the cytocompatibility, and consequently 
one cell activity and remodeling [87] . 
The release of ions incorporated in direct or indirect way into 
he cements, has also shown effectiveness to increase the biolog- 
cal performance of the materials. An example is the combination 
f brushite cements (BR) and bioglass 45S5, which contains Si 4 + , 
a 2 + and P 3 − ions, that results in increased material resorption and 
one tissue integration [88] . In vitro assays of the composite ce- 
ents of brushite with 40% bioglass microspheres (BR/BM) seeded 
n MC3T3-E1 cells showed a positive effect of ionic release and 
issolution products on cell growth and proliferation ( Fig. 10 a and 
). Large number of nuclei was observed in the materials after 14 
nd 21 days of culture with osteopontin (OPN) expression higher 
n the composite materials at 14 days ( Fig. 10 c and d). Ca 2 + and
i 4 + ions released from the cements were able to produce a su- 
erficial layer that interacts with cells stimulating cell attachment, 
roliferation and differentiation indicating retention of solubility of 
he bioglass. 
Osteoclasts fusion of peripheral blood mononuclear cells have 
lso been shown to decrease with high Sr 2 + release from brushite 
ements containing gelatin [89] . The osteoclast related gene ex- 
ression markers DC-Stamp and CD44 were downregulated when 
n contact with the materials. 
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Fig. 10. In vitro biocompatibility tests using MC3T3E1 cells cultured on the cements: MTT assay (a); F-actin staining (b); Immunofluorescence detection micrographs of 


























































materials. .3.3. Osteogenesis and Angiogenesis 
The mechanism involving bone formation is centred on osteo- 
enesis, strongly linked with angiogenesis or blood vessel forma- 
ion. Vascularisation is essential to engineer functional implants for 
one repair and regeneration, when blood vessels are concerned 
or oxygen and nutrients delivery [90] . One of the main beneficial 
roperties of CaPs-based materials is their osteoconductive capac- 
ty of new bone formation. Recently, CaPs ceramics are also recog- 
ized to possess intrinsic osteoinductivity due to their capacity to 
nduce new bone formation in nonosseous sites in the absence of 
rowth factors and signalling molecules [91] . This phenomenon is 
elated to the materials ́structural and physicochemical properties, 
uch as the case of ion incorporation. Particular importance may 
e therefore given to ionic dopants involved in osteogenesis and 
ngiogenesis induction to regulate the bone repair process [12] . 
or example, an osteoinductive effect of brushite cements, contain- 
ng β-TCP doped with 0.49 wt% and 1.09 wt% Fe, was observed 
rom high levels of osteocalcin and Runx2 in MC3T3-E1 cells [21] . 
owever, the expression of Runx2 was higher in the cements with 
ower Fe content, indicating that the amount of Fe in the cements 
ay be adjusted for bone induction/growth achievement. 
The incorporation of Cu 2 + , Co 2 + or Cr 3 + is also of interest. A 
tudy by Schamel et al. [18] showed human mesenchymal stromal 
ells attaching and dispersion in the cements with low amounts 
10 mmol/mol β-TCP) of Cu 2 + , Co 2 + or Cr 3 + , after 1 day of culture.
or higher amounts (50 mmol/mol β-TCP), the cells were observed 
nly on Cr 3 + -doped cements and ALP activity increased with in- 
reasing Cr 3 + amounts, indicating osteogenic differentiation. Fur- 
hermore, the highest rate of newly formed bone after 6 months 
f cements implantation in male adult Wistar rats was observed 
or 50 mmol Cr 3 + ( Fig. 11 I) [39] . Lamellar bone has grown from14 he defect margin into the central part, showing Haversian canals 
steons ( Fig. 11 II). 
Si 4 + and Zn 2 + are other dopants known for their beneficiary 
ffects on bone growth and angiogenesis [ 32 , 43 ]. The osteogenic 
otential of 0.25 wt% Zn + 0.5 wt% Si-doped brushite cements was 
bserved by well matured new tissue formation after 3 months of 
mplantation in epiphyseal femurs of New Zealand white rabbits, 
wing to Zn/Si doping [43] . When the composites were cultured 
ith endothelial cells, a favored survival was observed through 
ube formation and higher functionality in terms of nitric oxide 
ecretion, proving the ability of Si/Zn dopants in triggering angio- 
enic signalling ( Fig. 12 ). Similarly, an acceleration of neoosseous 
ormation, despite high osteoclast activity, was also observed for 
igher (0.5, 0.8, and 1.1 wt%) Si 4 + amounts [29] . In vivo studies 
ere carried out by implanting these cements in rat distal femurs 
howing a complete bone formation after 12 weeks and blood ves- 
el formation after 4 and 8 weeks. Significant enhancement of vas- 
ulogenesis was observed at 8 weeks of implantation due to the 
resence of Si 4 + and its amount ( Fig. 13 ). 
A different approach to evaluate the role of ionic dopants on 
rushite cements were reported using β-TCP synthesized from 
ggshells as brushite precursor [92] . In vivo studies of the cements 
erformed in rat calvarial bone defect for 12 weeks revealed faster 
egradation and accelerated bone formation. New blood vessels 
nd formation of woven bone on the edges of the defect were 
bserved after 6 months of cement implantation. This enhanced 
one regenerative capacity was attributed to the use of natural 
ources as eggshells, which contain relevant trace elements (e.g. 
g 2 + , Sr 2 + , Si 4 + , F –, K + and Na + ) along with calcium, result-
ng in improved physicochemical and biological properties of the 
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Fig. 11. Masson-Goldner trichrome staining of the explants of two animals per group after 6 months of implantation in male adult Wistar rats: I) Morphological (arrows = os- 
teons including Haversian canals) (A) and Histomorphometric examination (n = 4; ∗p < 0.05) (B); II) Morphological evaluation of the histological sections. Reprinted with 



























































Sr 2 + is another relevant trace element known for its stimulatory 
ffect on bone forming [12] . For example, Fang et al. investigated 
he in vivo performance of brushite cements doped with 5% Sr 2 + 
y implanting them in alveolar bone defects in osteoporotic rab- 
its [37] . Results have shown the bone defect nearly filled after 8 
eeks and highest β-FGF expression at 4 weeks of implantation. 
.3.4. Antibacterial activity 
Complications as infection and inflammation of the defect site 
re serious issues in orthopaedics, leading to severe pain and in 
ome cases, the implants removal. Hence, the use of antibiotics 
an be effective to contain these risks, but there is the problem 
f rising immunity of bacteria to traditional antibiotics [93] . Ionic 
opants with antibacterial action appeared as a promising alterna- 
ive approach to prevent infections in the medical field. 
Ag + , Zn 2 + and Cu 2 + are the most broadly used as ionic dopants 
ith antibacterial properties [ 31 , 74 , 94-96 ]. Ag + doped brushite ce-
ents were shown to reduce Staphylococcus aureus ( S. aureus ) ad- 
esion with an antibacterial effect of 85 % and an inhibitory effect 
owards pathogenic Escherichia coli ( E. coli ) for Ag + amounts of 0.6 
nd 1 wt%, while the effect was better for higher Ag concentrations 
 22 , 35 ]. 
The antibacterial effect of Cu 2 + in brushite cements was 
lso observed against Gram-negative bacteria E. coli, Pseudomonas 
eruginosa ( P. aeruginosa ) and Salmonella enteritidis ( S. enteritidis ) 
or Cu 2 + content of 0.3 wt% [38] . Interestingly, it was observed that 
he antibacterial activity of the cements was significantly higher 
han that of the CuTCP precursor powder, although the Cu 2 + re- 
ease from the powder exceeded that from the cement ( Fig. 14 ). 
ince in the first hour the Cu 2 + release from the cement was six 
imes higher than that from the powder, it was concluded that this 
urst increases the antibiotic efficacy. Additionally, a synergy be- 
ween cationic Cu 2 + and a particular phase and aggregation state 15 f the CaP carrier was proposed. Likewise, an inhibitory effect 
owards pathogenic E. coli was reported for cements containing 
.6 wt% Zn 2 + [30] . It was observed that higher Zn 2 + concentration 
ed to the increase of the inhibition zone diameter. 
Another interesting ion to be used against bacteria is Fe, partic- 
larly when possible side effects of Ag + , like allergies or chronic 
kin changes, can occur [ 21 , 27 , 97 ]. Li et al. [27] reported the
fficient antibacterial properties of Fe 2 + -doped brushite cements 
gainst S. aureus and P. aeruginosa , but less efficiency against E. coli 
27] . The authors attributed this fact to the interaction between 
he particles and cell surfaces or to the reaction of Fe 2 + with en- 
ogenous hydrogen peroxide, which can induce lethality in bacte- 
ia. On the other side, Uskokovic et al. [21] observed that the an- 
ibacterial activity of Fe-doped brushite cements against E. coli, S. 
nteritidis, P. aeruginosa , and S. aureus , increased with Fe content 
ncrease ( Fig. 15 ). Distinct inhibition zones were observed around 
ll the cement compositions and an effect was interestingly no- 
iced only against E. coli and S. enteritidis strains in broth assay 
ith no critical effect of iron concentration. 
.3.5. Drug delivery systems 
Osteomyelitis, a bone infection mainly caused by bacteria, my- 
obacteria or fungi, is a serious issue related with the treatment of 
one defects. It is normally treated by operative debridement and 
ntibiotic therapy [98] . Treatment of the disease can fail due to 
he inability to maintain high concentrations of antibiotics at the 
nfection site. Filling the infected bone site with an antibiotic bone 
raft is a promising approach to ensure high local concentration of 
he antibiotic. CPCs have been investigated as good drug and bioac- 
ive signalling molecules (e.g. bone morphogenetic protein (BMP), 
ecombinant human BMP-2 (rhBMP-2), insulin like growth factor 
IGF), and transforming growth factor β (TGF- β)) carriers for min- 
ralized tissues [99-106] . These materials have the advantage of a 
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Fig. 12. Angiogenic performance of Si/Zn-doped brushite cements (BrC) /silk fibroin (SF) composites: (A) calcein-AM stained porcine endothelial cells for SF (i), BrC/SF (ii), 
Si-BrC/SF (iii), Zn-BrC/SF (iv), and Zn + Si-BrC/SF (v); (vi) tube length, and (vii) number of tubes and nodes noticed per imaging field from the fluorescent micrographs; (B) 
endothelial cells viability: unstained cells (i), SF (ii), BrC/SF (iii), Si-BrC/SF (iv), Zn-BrC/SF (v), Zn + Si-BrC/SF (vi), endothelial cells control (vii) and percentage of dead cell 
population (viii); (C) alamar blue assay; and (D) biochemical estimation of endothelial nitric oxide (NO) (#p ≤ 0.05). Reprinted with permission from [43] . Copyright (2019) 
















s  ow setting temperature, which also enables the incorporation of 
eat-labile drugs. The drug release profile is also relevant concern- 
ng to achieve the desired clinical outcome. One option to adjust 
he release profile is via the cement porosity, which can in turn be 
djusted by liquid/cement ratio [107] . 
Another important issue is the incorporation of the drug inside 
PC. The drug can be incorporated in the powder or in the liquid 
f the cements, and its release will depend on the cements degra- 
ation ( Fig. 16 ): (i) the release is controlled by diffusion through 16 he fluid permeating the cement, if its degradation is slower than 
iffusion ( Fig. 16 a); (ii) the release is controlled by cement degra- 
ation, if it is faster than diffusion ( Fig. 16 b); and (iii) in the cases
f an apatite layer is formed, the drug diffusion can be delayed 
 Fig. 16 c) [101] . 
Although very few studies regarding ion-doped brushite ce- 
ents used as drug and biomolecules carriers are reported, these 
iomaterials are very interesting for such purpose, due to their low 
etting reaction and intrinsic porosity [ 24 , 26 , 32 , 41 ]. For example,
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Fig. 13. (a) Photomicrographs of von Willebrand factor staining of the tissue sections after 4 and 8 weeks of implantation; and (b) histomorphometric analysis showing new 

















































abrejos-Azama et al. [41] investigated a Mg 2 + -doped brushite ce- 
ent as a carrier for vancomycin delivery against S. aureus and 
ost of Gram-positive bacteria. It was observed that the drug re- 
ease was dependent of the amount of Mg 2 + in the cements, be- 
ng fast for 26.67 mol% MgTCP and slow for higher Mg 2 + con- 
entrations. In contrast, nearly no effect was observed when the 
rug was loaded by adsorption. Accordingly, the sample with 
6.67 mol% Mg 2 + showed an initial abrupt of vancomycin re- 
ease, possibly owed to higher porosity and specific surface area 
f the cement. Saleh et al. [24] examined the release of gentam- 
cin sulfate, amoxicillin and ampicillin trihydrate from brushite ce- 
ents containing Mg 2 + . They observed a burst release in the first 
2 hours, which was attributed to a release of the drug adsorbed 
n the outer sample surface. This was followed by a controlled 
ontinuous release, which was explained by the release of the 
rug incorporated within the cement network. The release profiles 
howed a continuous drug release over 14 days, with cumulative 
eleases of 99.3%, 87%, and 79%, respectively for gentamicin sulfate, 
moxicillin, and ampicillin trihydrate. 
In another study by Taha et al. [26] , the use of brushite cements
ontaining 6.6 wt% Sr 2 + as a carrier for gentamicin sulfate, amox- 
cillin and ampicillin trihydrate was also investigated. It was ob- 
erved an initial followed by a slow burst release for 14 days, with 
 cumulative release of 65%, 57% and 47% for undoped cements, 
espectively for gentamicin sulfate, amoxicillin, and ampicillin tri- 17 ydrate ( Fig. 17 a). A noticed increase of drug release was observed 
n the first 72 hours by using Sr-doped cements, of 96%, 87% and 
3%, respectively for gentamicin sulfate, amoxicillin, and ampicillin 
rihydrate ( Fig. 17 b). 
Recently, the influence of Si doping (40% and 80% [Si/(Si + P)] 
olar ratio) for drug loading and delivery was evaluated in two 
ifferent materials with different porosity and specific surface area, 
amely Si-doped β-TCP ceramics and Si-doped brushite cements 
42] . It was observed that 98 % of vancomycin was released from 
he Si-ceramics after 168 hours, being slower than in undoped ce- 
amics. This fact was attributed to an anomalous transport mech- 
nism, according to the Korsmeyer-Peppas model. The release of 
0 mg/mL vancomycin for Si-cements containing β-TCP with a 
Si/(Si + P)] molar ratio of 40% and 80% was respectively, 93% and 
2% after 157 hours. Therefore, the authors concluded that the van- 
omycin release rate was better controlled when Si was incorpo- 
ated into the materials, and the cements with higher Si content 
resented a decreased and controlled release rate. 
Ion-doped brushite cements have also been useful as growth 
actors delivery systems [32] . A study by Vahabzadeh et al. [32] re- 
orted that IGF-1 loading on 0.5 wt% Si/0.25 wt% Zn-doped ce- 
ents presented reasonably enhanced new osseous tissue forma- 
ion after 4 months of implantation in rabbit distal femurs, in com- 
arison to unloaded cements. Furthermore, IGF-1 led to the forma- 
ion of collagen network and bone cell colonization matrix. 
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Fig. 14. Assays carried out against Gram-positive S. aureus (a, e, i, m) and Gram-negative P. aeruginosa (b, f, j, n), S. enteritidis (c, g, k, o) and E. coli (d, h, l, p). Bacterial 
inhibition zones around the CuTCP cement (a–d) and absent around the CuTCP precursor (e–h) and around TCP cement (i–l) and in TCP precursor (m–p). Reprinted with 
permission from [38] . 
Fig. 15. Antibacterial assays of Fe-doped cements: I) diameter of the inhibition zone (dz) and diameter of the spherical cement sample deposit (ds) on an agar plate after 
24 h inoculation with E. coli, S. enteritidis, P. aeruginosa or S. aureus; and II) visual images of bacteria inhibition zones around Fe-cements for different bacterial cultures. 
Carbonated HAp: with a precursor HAp component of the cement formulation; Low Fe: Fe-doped cement containing 0.49 wt%; High Fe: Fe-doped cement containing 1.09 
wt%. Data are shown as averages with error bars representing standard deviation ( ∗p < 0.05). Reprinted with permission from [21] . 
Fig. 16. Different states of drug release from CPCs. Adapted with permission from [101] . 
18 
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Fig. 17. Release profiles of gentamicin sulfate, amoxicillin, and ampicillin trihydrate evaluated in a) undoped brushite cements (BrC) and b) Sr-doped brushite cements 












































































. Conclusions and future trends 
Several properties of brushite cements can be effectively im- 
roved by the addition of inorganic dopants for the development 
f the next generation biomaterials for bone and periodontal de- 
ects repair and regeneration. Ionic substitutions or dopants can 
ave an impact on various features, ranging from the biological 
erformance like cell interactions, osteogenic/angiogenic potential 
r even antibacterial traits to physicochemical properties like set- 
ing time, injectability or mechanical performance. Sometimes syn- 
rgistic effects can be reached, when ions with positive impact 
n the biological performance can also improve the setting perfor- 
ance or mechanical properties. But on the other hand, ion doping 
enefits with respect to one aspect can have a detrimental effect 
n other properties. Hence, for successful biomedical applications 
f ion doping, it is of high importance to assess the impact of each 
on in all fields of relevant brushite cement properties. The concen- 
ration of the ion of interest needs to be carefully chosen in order 
o obtain sufficient efficacy with respect to the targeted properties, 
ut at the same time to avoid negative side effects resulting from 
verdosage. The degradation of the cements, as well as the release 
rofile for the specific ion need to be considered. Main concerns 
re related to adequate amounts of released ions in in vivo sce- 
ario, with positive therapeutic and regenerative levels. 
Concerning the extensive research reporting the efficacy of CPCs 
s carrier materials for controlled drug/antibiotics/growth factors 
elivery to bone, further research needs to be devoted to ion- 
oped brushite cements. These cements possess fast resorption 
ate in vivo , which enhance the drug mobility for several therapeu- 
ic applications. Ion incorporation offers a high potential to provide 
one regeneration capacity (e.g. Sr 2+ , Zn 2+ , Mg 2+ , and Si 4+ ) and an-
ibacterial activity (e.g. Ag + and Cu 2+ ). 
Despite the work performed so far, some obstacles remain that 
inder a fast-clinical translation. Moreover, it has to be considered 
hat data sets for ion-doped cements obtained from different stud- 
es are not directly comparable, since especially physical properties 
ike setting time, injectability and mechanical properties are not 
nly affected by dopant ions, but also by other factors like syn- 
hesis conditions and the resulting grain size of the starting pow- 
ers, the LPR of the cement pastes and other possible cement ad- 
itives as organic compounds. Therefore, in order to directly com- 
are the effect of different ions on specific cement properties like 
he setting time, broader studies including the most promising 
ons would be highly valuable. Here, equal synthesis conditions, 
s well as cement paste compositions for all ions under investiga- 19 ion should be ensured to exclude the effect of other parameters. 
ith respect to the biological performance, long-term studies and 
 deeper understanding of these dopants mechanism behaviour are 
till needed, for new biomedical products regulation and to turn 
hem clinically accessible. Promising research directions that are 
eing explored comprise 3D printing technology for the fabrica- 
ion of personalized brushite-based scaffolds as bone grafts, able 
o promote bone ingrowth and osteoinductivity capability. 
tatement of significance 
Ion-doped brushite cements have unbolted a new era in or- 
hopaedics with high clinical interest to restore bone defects and 
acilitate the healing process, owing its outstanding bioresorbabil- 
ty and osteoconductive/osteoinductive features. Ion incorporation 
xpands their application by increasing the osteogenic and neovas- 
ularization potential of the materials, as well as their mechanical 
erformance. Recent accomplishments of brushite cements incor- 
orating bioactive ions are overviewed. Focus was placed on the 
ole of ions on the physicochemical and biological properties of the 
iomaterials, namely their structure, setting time, injectability and 
andling, mechanical behaviour, ion release and in vivo osteogen- 
sis, angiogenesis and vascularization. Antibacterial activity of the 
ements and their potential use for delivery of drugs are also high- 
ighted herein. 
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